European Archives - Page 518 of 1127 - European Medical Journal

Spoonful of technology: February 2023

GOLD reviews the top stories in health technology from the past few months, highlighting how tech is changing treatment landscapes and patient experiences.

Disability and Death Risk Increased in COVID-19-Associated Stroke

Many patients with COVID-19 present at the hospital with symptoms of acute ischaemic stroke, caused by a sudden blockage of blood flow…

Could Smartphones Diagnose and Track Neurological Conditions?

Allow neurologists and patients to capture important clinical data using readily available technology, such as smartphones and tablets…

Dermatology CP

Paget Disease of Skin Secondary to Urothelial Carcinoma

Currently, the exact mechanism underlying EMPD is unknown, but two widely known theories exist, namely the epidermotropic and transformation theories.

EMJ Hematology 10 [Supplement 2] 2022

EXPERT discussion from a satellite symposium presented at the European Hematology Association (EHA) Virtual Congress 2021 focused on myelodysplastic syndrome (MDS), a heterogeneous group of myeloid malignancies characterised by ineffective haematopoiesis, progressive bone marrow failure, and increased risk of acute myeloid leukaemia evolution.

Idarucizumab in Emergent Pericardiocentesis

A 71-year-old male with atrial fibrillation (AF) was admitted to the authors’ emergency department with fever, progressive dyspnoea…

Treatment with Hyaluronic Acid Injections in a Patient with Craniosynostosis

A case of a 25-year-old White female left with residual bone deformity after surgical correction of craniosynostosis during childhood…

EMJ

The Search for Sustained Durability in Higher-Risk Myelodysplastic Syndrome: New Treatment Pathways in Sight

Higher-risk MDS is a collective term based on the Revised International Prognostic Scoring System (IPSS-R) that encompasses…

New Developments, Data, and Guideline Updates: Direct Oral Anticoagulants for the Treatment of Venous Thromboembolism Associated with Cancer – Interviews with Key Opinion Leaders

CAT is a serious complication that can affect up to 6% of patients with cancer, and is associated with a 2–5-fold increased risk of…

EMJ Oncology 10 [Supplement 3] 2022

In this interview, they discuss the role of direct oral anticoagulants (DOAC) as a treatment for cancer-associated thrombosis (CAT)…